Having condomless sex & other things we learnt on day 1 of Aids conference

Posted by parceline on

Wednesday, July 25, 2018

2. Two drugs keep HIV under control as well as three

It is the norm that all antiretroviral treatment requires three drugs to prevent the body becoming resistant to the drugs. Even the South African government-provided single pill a day consists of three different ARV medicines.

But a trial in Argentina and parts of Africa‚ Europe and Asia Pacific show a new medicine of two drugs‚ called Dolutegravir and Lamivudine‚ worked as well as a common ARV drug with three medicines.

In the study‚ 1‚400 HIV-positive adults were put on treatment for first time and half got the new treatment and the other half the three drugs. Their health was later compared.

Researchers said the two-in-one treatment could "be an opportunity to reduce treatment costs and reduce side effects".

3. More concern about birth defects in HIV wonder drug

Dolutegravir is a newish HIV drug expected to be used in South Africa next year‚ instead of a drug currently used now called Efavirenz. It has almost no side effects and people do not become resistant to it.

There is one recorded case of resistance of the 600‚000 people using it abroad in America and Europe‚ Wits Reproductive Health and HIV Institute Professor Francois Venter has previously told TimesLIVE.

The fact you can’t become resistant to Dolutegravir means the medicine won’t stop working and leave users to die from Aids.

Let's block ads! (Why?)

Labels: Viral Today

Thanks for reading Having condomless sex & other things we learnt on day 1 of Aids conference. Please share...!